The summer oncology conferences are drawing nearer, and so to is the abstract release date for ASCO. For a complete overview of the timeline and abstract titles I am watching, check out my previous piece: ASCO Alert: Stay Ahead of the Updates. These past few trading session have been overshadowed by trade war fears and volatility. One small cap oncology company that has been hit extremely hard is TG Therapeutics (TGTX). Since May 7th, TGTX has dropped just over 20% from its top . . .
About Chris Stang
As a young investor, I focus developing biotech companies. I focus strongly on fundamentals, digging deeper to understand the financial and regulatory position of companies. The biotechnology sector is very volatile, please use caution and do your own additional due diligence before investing. I also secondarily focus on small security and defense companies that provide long-term growth opportunities.